Richard Onanga
- Virology top 1%
- HIV Research and Treatment 15
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 5
- HIV/AIDS Research and Interventions 5
- Immunology top 10%
- Epidemiology top 10%
- Herpesvirus Infections and Treatments 7
- Urinary Tract Infections Management 6
-
- Antibiotic Resistance in Bacteria 13
-
- Bacterial Identification and Susceptibility Testing 6
-
- Reproductive tract infections research 4
Richard Onanga
49 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 73
- Virology 685
- Infectious Diseases 342
- Immunology 343
- Applied Microbiology and Biotechnology 25
- Epidemiology 428
Countries citing papers authored by Richard Onanga
This map shows the geographic impact of Richard Onanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Onanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Onanga more than expected).
Fields of papers citing papers by Richard Onanga
This network shows the impact of papers produced by Richard Onanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Onanga. The network helps show where Richard Onanga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Onanga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 1 | |
| 14 | 2011 | 2 | |
| 15 | 2006 | 52 | |
| 16 | 2005 | 2 | |
| 17 | 2005 | 206 | |
| 18 | 2004 | 14 | |
| 19 | 2002 | 31 | |
| 20 | 2001 | 5 |
About Richard Onanga
Richard Onanga is a scholar working on Virology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), Antibiotic Resistance in Bacteria (13 papers), Herpesvirus Infections and Treatments (7 papers), Urinary Tract Infections Management (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and Reproductive tract infections research (4 papers). The work is most often cited by research in Virology (685 citations), Infectious Diseases (342 citations) and Immunology (343 citations). Richard Onanga has collaborated with scholars based in Gabon, France and United States. Frequent co-authors include Cristian Apetrei, Pierre Roques, Ivona Pandrea, François Simon, Maria Makuwa, Pierre Rouquet, C.G. Kornfeld, Sandrine Souquière, Michaela Müller‐Trutwin and Preston A. Marx. Their work appears in journals such as Journal of Virology, Journal of Clinical Investigation, Antibiotics, AIDS Research and Human Retroviruses and American Journal of Tropical Medicine and Hygiene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.